(Save the date: RealShare Medical Office buildings comes to the Four Seasons in Scottsdale, AZ November 7 -8 2012)

NEW HAVEN-A international biopharmaceutical company has become the fourth major corporation to benefit from the state of Connecticut’s “First Five” program designed to spur economic development and job creation. At a press conference on Tuesday, Governor Dannel P. Malloy announced that Alexion Pharmaceuticals Inc. will relocate from its current facility in suburban Cheshire, CT to establish a new, state-of-the-art global headquarters in New Haven’s central business district.

Locally-based Winstanley Enterprises has been selected to develop the $100 million office/lab project on a newly-developed block at 100 College St. in the emerging Downtown Crossing neighborhood, which is located in close proximity to Yale-New Haven Hospital. The governor said Alexion will move more than 350 employees to the new facility, and the entire project is expected to create 200 to 300 new jobs in the state by 2017.